This document discusses the challenges of rationing scarce medical resources during the Covid-19 pandemic. It notes that rationing has already begun with shortages of masks, ICU beds, and ventilators in various countries. The document estimates the potential health impacts and demands on the healthcare system of a moderate or severe Covid-19 pandemic based on models and early data. Even conservative estimates show Covid-19 infections and hospitalizations will exceed normal U.S. healthcare capacity. Shortages of beds, ventilators, staff, and protective equipment are likely as the pandemic progresses. Fair allocation of limited resources will be needed as demand outstrips supply.
This report specifically looks at the impact COVID-19 has had on nursing homes and the nursing home industry. Contributors are students, faculty, and alumni located in a variety of geographic locations from Yale, Tulane, and Sacred Heart Universities. It provides information gathered from situation reports, government and non-governmental organization, media reporting, and a variety of information sources, verifies and synchronizes the information and provide real-time information products to federal, state, local, nongovernmental and international response organizations.
This report specifically looks at the impact COVID-19 has had on nursing homes and the nursing home industry. Contributors are students, faculty, and alumni located in a variety of geographic locations from Yale, Tulane, and Sacred Heart Universities. It provides information gathered from situation reports, government and non-governmental organization, media reporting, and a variety of information sources, verifies and synchronizes the information and provide real-time information products to federal, state, local, nongovernmental and international response organizations.
Contributors are students, faculty, and alumni located in a variety of geographic locations from Yale, Tulane, and Sacred Heart Universities. It provides information gathered from situation reports, government and non-governmental organization, media reporting, and a variety of information sources, verifies and synchronizes the information and provide real-time information products to federal, state, local, nongovernmental and international response organizations.
Selon une étude, publiée en décembre 2020, la population de la ville de Manaus (Brésil) aurait atteint l’immunité collective. Laurent AVENTIN, PhD – Consultant en santé publique, fait le point pour Le Courrier des Stratèges…
Contributors are students, faculty, and alumni located in a variety of geographic locations from Yale, Tulane, and Sacred Heart Universities. It provides information gathered from situation reports, government and non-governmental organization, media reporting, and a variety of information sources, verifies and synchronizes the information and provide real-time information products to federal, state, local, nongovernmental and international response organizations.
A new CDC report finds that hepatitis A infections in the U.S. have risen by 294% since 2015. In nine states and Washington, D.C., the increase in rates was 500% compared to previous years. Hepatitis A, which is the most common cause of viral hepatitis worldwide, is spread fecal-orally after contact with an infected person but is preventable through a vaccine. In the new report, which looked at transmissions between 2016 and 2018, the CDC received 15,000 reports of infections in the U.S.: People who reported drug use or homelessness made up the majority of those who had infections, followed by cases among men who have sex with men and among people who ate contaminated food.
Contributors are students, faculty, and alumni located in a variety of geographic locations from Yale, Tulane, and Sacred Heart Universities. It provides information gathered from situation reports, government and non-governmental organization, media reporting, and a variety of information sources, verifies and synchronizes the information and provide real-time information products to federal, state, local, nongovernmental and international response organizations.
Selon une étude, publiée en décembre 2020, la population de la ville de Manaus (Brésil) aurait atteint l’immunité collective. Laurent AVENTIN, PhD – Consultant en santé publique, fait le point pour Le Courrier des Stratèges…
Contributors are students, faculty, and alumni located in a variety of geographic locations from Yale, Tulane, and Sacred Heart Universities. It provides information gathered from situation reports, government and non-governmental organization, media reporting, and a variety of information sources, verifies and synchronizes the information and provide real-time information products to federal, state, local, nongovernmental and international response organizations.
A new CDC report finds that hepatitis A infections in the U.S. have risen by 294% since 2015. In nine states and Washington, D.C., the increase in rates was 500% compared to previous years. Hepatitis A, which is the most common cause of viral hepatitis worldwide, is spread fecal-orally after contact with an infected person but is preventable through a vaccine. In the new report, which looked at transmissions between 2016 and 2018, the CDC received 15,000 reports of infections in the U.S.: People who reported drug use or homelessness made up the majority of those who had infections, followed by cases among men who have sex with men and among people who ate contaminated food.
This presentatin examines the impact of Covid-19 on infectious diseases such as HIV and TB. The writer explores the impact of Covid-19 on the global landscape, the global public health system and how social and physical distancing rules at the workplace are making it impossible for optimal production capacity.
A Meta-Analysis of COVID-19. This meta-analysis does not provide all of the answers regarding the appropriate course of action but is intended to help provide clarity assessing many of the MEDICAL considerations at play in the current pandemic. A responsible course of action addressing this pandemic must balance out a range of interconnected Medical, Economic and Social considerations.
The value of real-world evidence for clinicians and clinical researchers in t...Arete-Zoe, LLC
In the midst of a rapidly spreading global pandemic, real-world evidence can offer invaluable insight into the most promising treatments, risk factors, and not only predict but suggest how to improve outcomes. Despite overwhelming news coverage, significant knowledge gaps regarding COVID-19 persist. The current uncertainties regarding incidence and the case fatality rate can only be addressed by widespread testing. But the paucity of testing, and diversity of approaches implemented in different countries, particularly among the general asymptomatic public, perpetuates a lack of understanding about spread and infectivity. The essential indicators that would describe the pandemic more accurately can be obtained using real-world data (RWD). To that purpose, we designed a data collection tool to collect data from hospitals that treat COVID-19 patients. The captured data will enhance our understanding of the COVID-19 pandemic, identify risk factors relevant for triage, relate to other similar seasonal infections and gain insight into the safety and efficacy of experimental and off-label therapies. Knowledge derived from a focused data collection effort will enable clinicians to adjust rapidly clinical protocols and discontinue interventions that turn out to be ineffective or harmful. By deploying our elegantly designed survey to capture routine clinical indicators, we avoid placing an additional burden on practitioners. Systematically generating real-world evidence can decrease the time to insight compared to randomized clinical trials, improving the odds for patients in rapidly changing conditions.
Emergency management 11
Emergency Management
Abstract:
In the month of December, 2019 there was outbreak of pneumonia with unknown reason in Wuhan, China. Wuhan is the center of attention because of the respiratory disorder cause by a virus called Corona and also known as Novel COVID – 19. Validate the existence of this virus was also diagnosed in Wuhan. Then it start spreading all over the world due to the social gatherings. It ultimately take thousands of people towards death. Then after its huge destruction a final step of lockdown is taken up by the government of each country. The animal-to-human transmission was presumed as the main mechanism. It was concluded that the virus could also be transmitted from human-to-human, and symptomatic people are the most frequent source of COVID-19 spread. The virus-host interaction and the evolution of the epidemic, with specific reference to the times when the epidemic will reach its peak.
Introduction:
There is scanty knowledge on the actual pandemic potential of this new SARS-like virus. It might be speculated that SARS-CoV-2 epidemic is grossly underdiagnosed and that the infection is silently spreading across the globe. There are no comparable analogies to corona virus. This virus is not like any of the other epidemiological threats that have emerged in recent decades; it is less fatal but much more contagious.
Distribution of cases by the following:
· Time: The outbreak of 2019 novel coronavirus disease (COVID-19) was first reported on December 31, 2019.
· Place: the epidemiology of 2019 novel coronavirus disease (COVID-19) in a remote region of China, far from Wuhan, we analyzed the epidemiology of COVID-19 in Gansu Province
Explanation of the research topic (corona virus):
As the outbreak of coronavirus disease 2019 (COVID-19) is rapidly expanding in China and beyond, with the potential to become a world-wide pandemic, real-time analyses of epidemiological data are needed to increase situational awareness and inform interventions. The current most likely hypothesis is that an intermediary host animal has played a role in the transmission. Identifying the animal source of the 2019-nCoV would help to ensure that there will be no further future similar outbreaks with the same virus and will also help understanding the initial spread of the disease.
Numerator (cases of corona virus):
Deaths divided the total of deaths plus recoveries. In early days because of the exponential increase new cases significantly outpace recoveries. You’re dividing by new cases but the numerator hasn’t had a chance to catch up to the death toll yet to be associated with those cases. If you look at COVID 19 on Feb 17, you get the 2% number only if dividing by total cases. If you look vs recovered cases, it’s 13%.
The WHO’s fatality percentage, announced March 17, 2020, is based simply on the number of deaths g.
HAI are a significant cause of increased morbidity and mortality in hospitalized patients. In addition, HAI lead to prolonged hospital stay, are inconvenient for the patients, and constitute huge economic burden on health care system. Studies have shown that HAI prevalence varies from 3.8% to 19.6% depending on the population surveyed with a pooled global prevalence of 10.1%.
As of the end of February, US COVID-19 cases have increased by 1.69 million (roughly 6%), indicating a decline in the rate of new cases across the U.S.
Review of Recent COVID-19 Science ~ Denis G. Rancourt, PhDPandataAnalytics
Measures do not prevent deaths, transmission is not by contact, masks provide no benefit, vaccines are inherently dangerous: Review update of recent science relevant to COVID-19 policy.
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)